244 related articles for article (PubMed ID: 1307347)
1. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
[TBL] [Abstract][Full Text] [Related]
2. Triethylene-tetramine (trien) therapy for Wilson's disease.
Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
Dubois RS; Rodgerson DO; Hambidge KM
J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
[TBL] [Abstract][Full Text] [Related]
4. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
5. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
Walshe JM
Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
[TBL] [Abstract][Full Text] [Related]
6. [A study of trientine therapy in Wilson's disease with neurological symptoms].
Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
[TBL] [Abstract][Full Text] [Related]
7. Wilson's disease.
Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
[TBL] [Abstract][Full Text] [Related]
8. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
10. Acquired sideroblastic anaemia induced by a copper-chelating agent.
Perry AR; Pagliuca A; Fitzsimons EJ; Mufti GJ; Williams R
Int J Hematol; 1996 Jul; 64(1):69-72. PubMed ID: 8757970
[TBL] [Abstract][Full Text] [Related]
11. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
[TBL] [Abstract][Full Text] [Related]
14. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
18. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
19. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Purchase R
Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
[TBL] [Abstract][Full Text] [Related]
20. Recognition, diagnosis, and management of Wilson's disease.
Brewer GJ
Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]